<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34780101</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1522-2586</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>55</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of magnetic resonance imaging : JMRI</Title>
          <ISOAbbreviation>J Magn Reson Imaging</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Reliability and Sensitivity to Longitudinal CBF Changes in Steno-Occlusive Diseases: ASL Versus <sup>123</sup> I-IMP-SPECT.</ArticleTitle>
        <Pagination>
          <StartPage>1723</StartPage>
          <EndPage>1732</EndPage>
          <MedlinePgn>1723-1732</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jmri.27996</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Noninvasive cerebral blood flow (CBF) monitoring using arterial spin labeling (ASL) magnetic resonance imaging is useful for managing large cerebral artery steno-occlusive diseases. However, knowledge about its measurement characteristics in comparison with reference standard perfusion imaging is limited.</AbstractText>
          <AbstractText Label="PURPOSE">To evaluate perfusion in a longitudinal manner in patients with steno-occlusive disease using ASL and compare with single-photon emission computed tomography (SPECT).</AbstractText>
          <AbstractText Label="STUDY TYPE">Prospective.</AbstractText>
          <AbstractText Label="POPULATION">Moyamoya (n = 10, eight females) and atherosclerotic diseases (n = 2, two males).</AbstractText>
          <AbstractText Label="FIELD STRENGTH/SEQUENCE">3.0 T; gradient-echo three-dimensional T<sub>1</sub> -weighted and spin-echo ASL.</AbstractText>
          <AbstractText Label="ASSESSMENT">Multi-delay ASL and [<sup>123</sup> I]-iodoamphetamine SPECT CBF measurements were performed both before and within 9 days of anterior-circulation revascularization. Reliability and sensitivity to whole-brain voxel-wise CBF changes (ΔCBF) and their postlabeling delay (PLD) dependency with varied PLDs (in milliseconds) of 1000, 2333, and 3666 were examined.</AbstractText>
          <AbstractText Label="STATISTICAL TESTS">Reliability and sensitivity to ΔCBF were examined using within-subject standard deviation (Sw) and intraclass correlation coefficients (ICCs). For statistical comparisons, standard deviation of longitudinal ΔCBF within the hemisphere contralateral to surgery, and the ratio between it and average ΔCBF within the ipsilateral regions of interest were subjected to paired t tests, respectively. P &lt; 0.05 was considered statistically significant.</AbstractText>
          <AbstractText Label="RESULTS">ASL test-retest time interval was 31 ± 18 days. Test-retest reliability was significantly lower for SPECT (0.16 ± 0.02) than ASL (0.13 ± 0.04). Sensitivity to postoperative changes was significantly higher for ASL (2.71 ± 2.79) than SPECT (0.27 ± 0.62). Test-retest reliability was significantly higher for a PLD of 2333 (0.13 ± 0.04) than 3666 (0.19 ± 0.05), and sensitivity to ΔCBF was significantly higher for PLDs of 1000 (2.53 ± 2.50) and 2333 than 3666 (0.79 ± 1.88). ICC maps also showed higher reliability for ASL than SPECT.</AbstractText>
          <AbstractText Label="DATA CONCLUSION">Higher test-retest reliability led to better ASL sensitivity than SPECT for postoperative ΔCBF. ASL test-retest reliability and sensitivity to ΔCBF were higher with a PLD of 2333.</AbstractText>
          <AbstractText Label="LEVEL OF EVIDENCE">1 TECHNICAL EFFICACY: Stage 2.</AbstractText>
          <CopyrightInformation>© 2021 International Society for Magnetic Resonance in Medicine.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Amemiya</LastName>
            <ForeName>Shiori</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-2132-1642</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takao</LastName>
            <ForeName>Hidemasa</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0001-7570-924X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watanabe</LastName>
            <ForeName>Yusuke</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takei</LastName>
            <ForeName>Naoyuki</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>MR Applications and Workflow, GE Healthcare, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ueyama</LastName>
            <ForeName>Tsuyoshi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kato</LastName>
            <ForeName>Seiji</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miyawaki</LastName>
            <ForeName>Satoru</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koizumi</LastName>
            <ForeName>Satoshi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abe</LastName>
            <ForeName>Osamu</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saito</LastName>
            <ForeName>Nobuhito</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Magn Reson Imaging</MedlineTA>
        <NlmUniqueID>9105850</NlmUniqueID>
        <ISSNLinking>1053-1807</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013113">Spin Labels</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>131-99-7</RegistryNumber>
          <NameOfSubstance UI="D007291">Inosine Monophosphate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>J Magn Reson Imaging. 2022 Jun;55(6):1733-1734</RefSource>
          <PMID Version="1">34874088</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002560" MajorTopicYN="Y">Cerebrovascular Circulation</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007291" MajorTopicYN="Y">Inosine Monophosphate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013113" MajorTopicYN="N">Spin Labels</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015899" MajorTopicYN="N">Tomography, Emission-Computed, Single-Photon</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">arterial spin labeling</Keyword>
        <Keyword MajorTopicYN="Y">cerebral blood flow</Keyword>
        <Keyword MajorTopicYN="Y">measurement reliability</Keyword>
        <Keyword MajorTopicYN="Y">perfusion imaging</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>15</Day>
          <Hour>12</Hour>
          <Minute>36</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34780101</ArticleId>
        <ArticleId IdType="doi">10.1002/jmri.27996</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: A large worldwide burden but a relatively neglected frontier. Stroke 2008;39:2396-2399.</Citation>
        </Reference>
        <Reference>
          <Citation>Andaluz N, Choutka O, Vagal A, Strunk R, Zuccarello M. Patient selection for revascularization procedures in adult Moyamoya disease based on dynamic perfusion computerized tomography with acetazolamide challenge (PCTA). Neurosurg Rev 2010;33:225-232; discussion 232-223.</Citation>
        </Reference>
        <Reference>
          <Citation>Juttukonda MR, Davis LT, Lants SK, et al. A prospective, longitudinal magnetic resonance imaging evaluation of cerebrovascular reactivity and infarct development in patients with intracranial stenosis. J Magn Reson Imaging 2021;54:912-922.</Citation>
        </Reference>
        <Reference>
          <Citation>Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;23:37-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 1992;89:212-216.</Citation>
        </Reference>
        <Reference>
          <Citation>Amemiya S, Watanabe Y, Takei N, et al. Arterial transit time-based multidelay combination strategy improves arterial spin labeling cerebral blood flow measurement accuracy in severe steno-occlusive diseases. J Magn Reson Imaging 2021. Online ahead of print. https://onlinelibrary.wiley.com/doi/10.1002/jmri.27823</Citation>
        </Reference>
        <Reference>
          <Citation>Fan AP, Guo J, Khalighi MM, et al. Long-delay arterial spin labeling provides more accurate cerebral blood flow measurements in Moyamoya patients: A simultaneous positron emission tomography/MRI study. Stroke 2017;48:2441-2449.</Citation>
        </Reference>
        <Reference>
          <Citation>Setta K, Matsuda T, Sasaki M, et al. Diagnostic accuracy of screening arterial spin-labeling MRI using Hadamard encoding for the detection of reduced CBF in adult patients with ischemic Moyamoya disease. AJNR Am J Neuroradiol 2021;42:1403-1409.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang R, Yu S, Alger JR, et al. Multi-delay arterial spin labeling perfusion MRI in moyamoya disease-Comparison with CT perfusion imaging. Eur Radiol 2014;24:1135-1144.</Citation>
        </Reference>
        <Reference>
          <Citation>Sugino T, Mikami T, Miyata K, Suzuki K, Houkin K, Mikuni N. Arterial spin-labeling magnetic resonance imaging after revascularization of moyamoya disease. J Stroke Cerebrovasc Dis 2013;22:811-816.</Citation>
        </Reference>
        <Reference>
          <Citation>Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60:1488-1497.</Citation>
        </Reference>
        <Reference>
          <Citation>Maleki N, Dai W, Alsop DC. Optimization of background suppression for arterial spin labeling perfusion imaging. Magma 2012;25:127-133.</Citation>
        </Reference>
        <Reference>
          <Citation>Vidorreta M, Wang Z, Rodríguez I, Pastor MA, Detre JA, Fernández-Seara MA. Comparison of 2D and 3D single-shot ASL perfusion fMRI sequences. Neuroimage 2013;66:662-671.</Citation>
        </Reference>
        <Reference>
          <Citation>Feng CM, Narayana S, Lancaster JL, et al. CBF changes during brain activation: fMRI vs. PET. Neuroimage 2004;22:443-446.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen JJ, Wieckowska M, Meyer E, Pike GB. Cerebral blood flow measurement using fMRI and PET: A cross-validation study. Int J Biomed Imaging 2008;2008:516359.</Citation>
        </Reference>
        <Reference>
          <Citation>Heijtel DF, Mutsaerts HJ, Bakker E, et al. Accuracy and precision of pseudo-continuous arterial spin labeling perfusion during baseline and hypercapnia: A head-to-head comparison with 15O H₂O positron emission tomography. Neuroimage 2014;92:182-192.</Citation>
        </Reference>
        <Reference>
          <Citation>Su Y, Vlassenko A, Blazey T, et al. Comparison of cerebral blood flow measurement obtained from simultaneously acquired ASL and O15-water PET. J Nucl Med 2014;55:207-207.</Citation>
        </Reference>
        <Reference>
          <Citation>Henriksen OM, Larsson HB, Hansen AE, Grüner JM, Law I, Rostrup E. Estimation of intersubject variability of cerebral blood flow measurements using MRI and positron emission tomography. J Magn Reson Imaging 2012;35:1290-1299.</Citation>
        </Reference>
        <Reference>
          <Citation>Sundt TM Jr, Sharbrough FW, Piepgras DG, Kearns TP, Messick JM Jr, O'Fallon WM. Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: With results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc 1981;56:533-543.</Citation>
        </Reference>
        <Reference>
          <Citation>Podreka I, Baumgartner C, Suess E, et al. Quantification of regional cerebral blood flow with IMP-SPECT. Reproducibility and clinical relevance of flow values. Stroke 1989;20:183-191.</Citation>
        </Reference>
        <Reference>
          <Citation>Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 1994;13:601-609.</Citation>
        </Reference>
        <Reference>
          <Citation>Chang L-T. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638-643.</Citation>
        </Reference>
        <Reference>
          <Citation>Dai W, Shankaranarayanan A, Alsop DC. Volumetric measurement of perfusion and arterial transit delay using hadamard encoded continuous arterial spin labeling. Magn Reson Med 2013;69:1014-1022.</Citation>
        </Reference>
        <Reference>
          <Citation>Wells JA, Lythgoe MF, Gadian DG, Ordidge RJ, Thomas DL. In vivo Hadamard encoded continuous arterial spin labeling (H-CASL). Magn Reson Med 2010;63:1111-1118.</Citation>
        </Reference>
        <Reference>
          <Citation>Dai W, Robson PM, Shankaranarayanan A, Alsop DC. Reduced resolution transit delay prescan for quantitative continuous arterial spin labeling perfusion imaging. Magn Reson Med 2012;67:1252-1265.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang X, Petersen ET, Ghariq E, et al. In vivo blood T(1) measurements at 1.5 T, 3 T, and 7 T. Magn Reson Med 2013;70:1082-1086.</Citation>
        </Reference>
        <Reference>
          <Citation>Wansapura JP, Holland SK, Dunn RS, Ball WS Jr. NMR relaxation times in the human brain at 3.0 Tesla. J Magn Reson Imaging 1999;9:531-538.</Citation>
        </Reference>
        <Reference>
          <Citation>Herscovitch P, Raichle ME. What is the correct value for the brain-blood partition coefficient for water? J Cereb Blood Flow Metab 1985;5:65-69.</Citation>
        </Reference>
        <Reference>
          <Citation>Alsop DC, Detre JA, Golay X, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73:102-116.</Citation>
        </Reference>
        <Reference>
          <Citation>Bland JM, Altman DG. Statistics notes: Measurement error. BMJ 1996;312:1654.</Citation>
        </Reference>
        <Reference>
          <Citation>Shrout PE, Fleiss JL. Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 1979;86:420-428.</Citation>
        </Reference>
        <Reference>
          <Citation>Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 1994;6:284-290.</Citation>
        </Reference>
        <Reference>
          <Citation>Schirmer MD, Giese AK, Fotiadis P, et al. Spatial signature of white matter hyperintensities in stroke patients. Front Neurol 2019;10:208.</Citation>
        </Reference>
        <Reference>
          <Citation>Donahue MJ, Lu H, Jones CK, Pekar JJ, van Zijl PC. An account of the discrepancy between MRI and PET cerebral blood flow measures. A high-field MRI investigation. NMR Biomed 2006;19:1043-1054.</Citation>
        </Reference>
        <Reference>
          <Citation>Reigel MM, Hollier LH, Sundt TM Jr, Piepgras DG, Sharbrough FW, Cherry KJ. Cerebral hyperperfusion syndrome: A cause of neurologic dysfunction after carotid endarterectomy. J Vasc Surg 1987;5:628-634.</Citation>
        </Reference>
        <Reference>
          <Citation>Yoneda H, Shirao S, Koizumi H, et al. Reproducibility of cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine in institutions with different γ-cameras and collimators. J Cereb Blood Flow Metab 2012;32:1757-1764.</Citation>
        </Reference>
        <Reference>
          <Citation>Cohen AD, Agarwal M, Jagra AS, et al. Longitudinal reproducibility of MR perfusion using 3D pseudocontinuous arterial spin labeling with Hadamard-encoded multiple postlabeling delays. J Magn Reson Imaging 2020;51:1846-1853.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim SH, Choi JU, Yang KH, Kim TG, Kim DS. Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg 2005;103:433-438.</Citation>
        </Reference>
        <Reference>
          <Citation>Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 2009;111:927-935.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu B, Lou X, Wu X, Ma L. Intra- and interscanner reliability and reproducibility of 3D whole-brain pseudo-continuous arterial spin-labeling MR perfusion at 3T. J Magn Reson Imaging 2014;39:402-409.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34780101</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1522-2586</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>55</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of magnetic resonance imaging : JMRI</Title>
          <ISOAbbreviation>J Magn Reson Imaging</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Reliability and Sensitivity to Longitudinal CBF Changes in Steno-Occlusive Diseases: ASL Versus <sup>123</sup> I-IMP-SPECT.</ArticleTitle>
        <Pagination>
          <StartPage>1723</StartPage>
          <EndPage>1732</EndPage>
          <MedlinePgn>1723-1732</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jmri.27996</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Noninvasive cerebral blood flow (CBF) monitoring using arterial spin labeling (ASL) magnetic resonance imaging is useful for managing large cerebral artery steno-occlusive diseases. However, knowledge about its measurement characteristics in comparison with reference standard perfusion imaging is limited.</AbstractText>
          <AbstractText Label="PURPOSE">To evaluate perfusion in a longitudinal manner in patients with steno-occlusive disease using ASL and compare with single-photon emission computed tomography (SPECT).</AbstractText>
          <AbstractText Label="STUDY TYPE">Prospective.</AbstractText>
          <AbstractText Label="POPULATION">Moyamoya (n = 10, eight females) and atherosclerotic diseases (n = 2, two males).</AbstractText>
          <AbstractText Label="FIELD STRENGTH/SEQUENCE">3.0 T; gradient-echo three-dimensional T<sub>1</sub> -weighted and spin-echo ASL.</AbstractText>
          <AbstractText Label="ASSESSMENT">Multi-delay ASL and [<sup>123</sup> I]-iodoamphetamine SPECT CBF measurements were performed both before and within 9 days of anterior-circulation revascularization. Reliability and sensitivity to whole-brain voxel-wise CBF changes (ΔCBF) and their postlabeling delay (PLD) dependency with varied PLDs (in milliseconds) of 1000, 2333, and 3666 were examined.</AbstractText>
          <AbstractText Label="STATISTICAL TESTS">Reliability and sensitivity to ΔCBF were examined using within-subject standard deviation (Sw) and intraclass correlation coefficients (ICCs). For statistical comparisons, standard deviation of longitudinal ΔCBF within the hemisphere contralateral to surgery, and the ratio between it and average ΔCBF within the ipsilateral regions of interest were subjected to paired t tests, respectively. P &lt; 0.05 was considered statistically significant.</AbstractText>
          <AbstractText Label="RESULTS">ASL test-retest time interval was 31 ± 18 days. Test-retest reliability was significantly lower for SPECT (0.16 ± 0.02) than ASL (0.13 ± 0.04). Sensitivity to postoperative changes was significantly higher for ASL (2.71 ± 2.79) than SPECT (0.27 ± 0.62). Test-retest reliability was significantly higher for a PLD of 2333 (0.13 ± 0.04) than 3666 (0.19 ± 0.05), and sensitivity to ΔCBF was significantly higher for PLDs of 1000 (2.53 ± 2.50) and 2333 than 3666 (0.79 ± 1.88). ICC maps also showed higher reliability for ASL than SPECT.</AbstractText>
          <AbstractText Label="DATA CONCLUSION">Higher test-retest reliability led to better ASL sensitivity than SPECT for postoperative ΔCBF. ASL test-retest reliability and sensitivity to ΔCBF were higher with a PLD of 2333.</AbstractText>
          <AbstractText Label="LEVEL OF EVIDENCE">1 TECHNICAL EFFICACY: Stage 2.</AbstractText>
          <CopyrightInformation>© 2021 International Society for Magnetic Resonance in Medicine.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Amemiya</LastName>
            <ForeName>Shiori</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-2132-1642</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takao</LastName>
            <ForeName>Hidemasa</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0001-7570-924X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watanabe</LastName>
            <ForeName>Yusuke</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takei</LastName>
            <ForeName>Naoyuki</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>MR Applications and Workflow, GE Healthcare, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ueyama</LastName>
            <ForeName>Tsuyoshi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kato</LastName>
            <ForeName>Seiji</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miyawaki</LastName>
            <ForeName>Satoru</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koizumi</LastName>
            <ForeName>Satoshi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abe</LastName>
            <ForeName>Osamu</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saito</LastName>
            <ForeName>Nobuhito</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Magn Reson Imaging</MedlineTA>
        <NlmUniqueID>9105850</NlmUniqueID>
        <ISSNLinking>1053-1807</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013113">Spin Labels</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>131-99-7</RegistryNumber>
          <NameOfSubstance UI="D007291">Inosine Monophosphate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>J Magn Reson Imaging. 2022 Jun;55(6):1733-1734</RefSource>
          <PMID Version="1">34874088</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002560" MajorTopicYN="Y">Cerebrovascular Circulation</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007291" MajorTopicYN="Y">Inosine Monophosphate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013113" MajorTopicYN="N">Spin Labels</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015899" MajorTopicYN="N">Tomography, Emission-Computed, Single-Photon</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">arterial spin labeling</Keyword>
        <Keyword MajorTopicYN="Y">cerebral blood flow</Keyword>
        <Keyword MajorTopicYN="Y">measurement reliability</Keyword>
        <Keyword MajorTopicYN="Y">perfusion imaging</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>15</Day>
          <Hour>12</Hour>
          <Minute>36</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34780101</ArticleId>
        <ArticleId IdType="doi">10.1002/jmri.27996</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: A large worldwide burden but a relatively neglected frontier. Stroke 2008;39:2396-2399.</Citation>
        </Reference>
        <Reference>
          <Citation>Andaluz N, Choutka O, Vagal A, Strunk R, Zuccarello M. Patient selection for revascularization procedures in adult Moyamoya disease based on dynamic perfusion computerized tomography with acetazolamide challenge (PCTA). Neurosurg Rev 2010;33:225-232; discussion 232-223.</Citation>
        </Reference>
        <Reference>
          <Citation>Juttukonda MR, Davis LT, Lants SK, et al. A prospective, longitudinal magnetic resonance imaging evaluation of cerebrovascular reactivity and infarct development in patients with intracranial stenosis. J Magn Reson Imaging 2021;54:912-922.</Citation>
        </Reference>
        <Reference>
          <Citation>Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;23:37-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 1992;89:212-216.</Citation>
        </Reference>
        <Reference>
          <Citation>Amemiya S, Watanabe Y, Takei N, et al. Arterial transit time-based multidelay combination strategy improves arterial spin labeling cerebral blood flow measurement accuracy in severe steno-occlusive diseases. J Magn Reson Imaging 2021. Online ahead of print. https://onlinelibrary.wiley.com/doi/10.1002/jmri.27823</Citation>
        </Reference>
        <Reference>
          <Citation>Fan AP, Guo J, Khalighi MM, et al. Long-delay arterial spin labeling provides more accurate cerebral blood flow measurements in Moyamoya patients: A simultaneous positron emission tomography/MRI study. Stroke 2017;48:2441-2449.</Citation>
        </Reference>
        <Reference>
          <Citation>Setta K, Matsuda T, Sasaki M, et al. Diagnostic accuracy of screening arterial spin-labeling MRI using Hadamard encoding for the detection of reduced CBF in adult patients with ischemic Moyamoya disease. AJNR Am J Neuroradiol 2021;42:1403-1409.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang R, Yu S, Alger JR, et al. Multi-delay arterial spin labeling perfusion MRI in moyamoya disease-Comparison with CT perfusion imaging. Eur Radiol 2014;24:1135-1144.</Citation>
        </Reference>
        <Reference>
          <Citation>Sugino T, Mikami T, Miyata K, Suzuki K, Houkin K, Mikuni N. Arterial spin-labeling magnetic resonance imaging after revascularization of moyamoya disease. J Stroke Cerebrovasc Dis 2013;22:811-816.</Citation>
        </Reference>
        <Reference>
          <Citation>Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60:1488-1497.</Citation>
        </Reference>
        <Reference>
          <Citation>Maleki N, Dai W, Alsop DC. Optimization of background suppression for arterial spin labeling perfusion imaging. Magma 2012;25:127-133.</Citation>
        </Reference>
        <Reference>
          <Citation>Vidorreta M, Wang Z, Rodríguez I, Pastor MA, Detre JA, Fernández-Seara MA. Comparison of 2D and 3D single-shot ASL perfusion fMRI sequences. Neuroimage 2013;66:662-671.</Citation>
        </Reference>
        <Reference>
          <Citation>Feng CM, Narayana S, Lancaster JL, et al. CBF changes during brain activation: fMRI vs. PET. Neuroimage 2004;22:443-446.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen JJ, Wieckowska M, Meyer E, Pike GB. Cerebral blood flow measurement using fMRI and PET: A cross-validation study. Int J Biomed Imaging 2008;2008:516359.</Citation>
        </Reference>
        <Reference>
          <Citation>Heijtel DF, Mutsaerts HJ, Bakker E, et al. Accuracy and precision of pseudo-continuous arterial spin labeling perfusion during baseline and hypercapnia: A head-to-head comparison with 15O H₂O positron emission tomography. Neuroimage 2014;92:182-192.</Citation>
        </Reference>
        <Reference>
          <Citation>Su Y, Vlassenko A, Blazey T, et al. Comparison of cerebral blood flow measurement obtained from simultaneously acquired ASL and O15-water PET. J Nucl Med 2014;55:207-207.</Citation>
        </Reference>
        <Reference>
          <Citation>Henriksen OM, Larsson HB, Hansen AE, Grüner JM, Law I, Rostrup E. Estimation of intersubject variability of cerebral blood flow measurements using MRI and positron emission tomography. J Magn Reson Imaging 2012;35:1290-1299.</Citation>
        </Reference>
        <Reference>
          <Citation>Sundt TM Jr, Sharbrough FW, Piepgras DG, Kearns TP, Messick JM Jr, O'Fallon WM. Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: With results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc 1981;56:533-543.</Citation>
        </Reference>
        <Reference>
          <Citation>Podreka I, Baumgartner C, Suess E, et al. Quantification of regional cerebral blood flow with IMP-SPECT. Reproducibility and clinical relevance of flow values. Stroke 1989;20:183-191.</Citation>
        </Reference>
        <Reference>
          <Citation>Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 1994;13:601-609.</Citation>
        </Reference>
        <Reference>
          <Citation>Chang L-T. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638-643.</Citation>
        </Reference>
        <Reference>
          <Citation>Dai W, Shankaranarayanan A, Alsop DC. Volumetric measurement of perfusion and arterial transit delay using hadamard encoded continuous arterial spin labeling. Magn Reson Med 2013;69:1014-1022.</Citation>
        </Reference>
        <Reference>
          <Citation>Wells JA, Lythgoe MF, Gadian DG, Ordidge RJ, Thomas DL. In vivo Hadamard encoded continuous arterial spin labeling (H-CASL). Magn Reson Med 2010;63:1111-1118.</Citation>
        </Reference>
        <Reference>
          <Citation>Dai W, Robson PM, Shankaranarayanan A, Alsop DC. Reduced resolution transit delay prescan for quantitative continuous arterial spin labeling perfusion imaging. Magn Reson Med 2012;67:1252-1265.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang X, Petersen ET, Ghariq E, et al. In vivo blood T(1) measurements at 1.5 T, 3 T, and 7 T. Magn Reson Med 2013;70:1082-1086.</Citation>
        </Reference>
        <Reference>
          <Citation>Wansapura JP, Holland SK, Dunn RS, Ball WS Jr. NMR relaxation times in the human brain at 3.0 Tesla. J Magn Reson Imaging 1999;9:531-538.</Citation>
        </Reference>
        <Reference>
          <Citation>Herscovitch P, Raichle ME. What is the correct value for the brain-blood partition coefficient for water? J Cereb Blood Flow Metab 1985;5:65-69.</Citation>
        </Reference>
        <Reference>
          <Citation>Alsop DC, Detre JA, Golay X, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73:102-116.</Citation>
        </Reference>
        <Reference>
          <Citation>Bland JM, Altman DG. Statistics notes: Measurement error. BMJ 1996;312:1654.</Citation>
        </Reference>
        <Reference>
          <Citation>Shrout PE, Fleiss JL. Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 1979;86:420-428.</Citation>
        </Reference>
        <Reference>
          <Citation>Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 1994;6:284-290.</Citation>
        </Reference>
        <Reference>
          <Citation>Schirmer MD, Giese AK, Fotiadis P, et al. Spatial signature of white matter hyperintensities in stroke patients. Front Neurol 2019;10:208.</Citation>
        </Reference>
        <Reference>
          <Citation>Donahue MJ, Lu H, Jones CK, Pekar JJ, van Zijl PC. An account of the discrepancy between MRI and PET cerebral blood flow measures. A high-field MRI investigation. NMR Biomed 2006;19:1043-1054.</Citation>
        </Reference>
        <Reference>
          <Citation>Reigel MM, Hollier LH, Sundt TM Jr, Piepgras DG, Sharbrough FW, Cherry KJ. Cerebral hyperperfusion syndrome: A cause of neurologic dysfunction after carotid endarterectomy. J Vasc Surg 1987;5:628-634.</Citation>
        </Reference>
        <Reference>
          <Citation>Yoneda H, Shirao S, Koizumi H, et al. Reproducibility of cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine in institutions with different γ-cameras and collimators. J Cereb Blood Flow Metab 2012;32:1757-1764.</Citation>
        </Reference>
        <Reference>
          <Citation>Cohen AD, Agarwal M, Jagra AS, et al. Longitudinal reproducibility of MR perfusion using 3D pseudocontinuous arterial spin labeling with Hadamard-encoded multiple postlabeling delays. J Magn Reson Imaging 2020;51:1846-1853.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim SH, Choi JU, Yang KH, Kim TG, Kim DS. Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg 2005;103:433-438.</Citation>
        </Reference>
        <Reference>
          <Citation>Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 2009;111:927-935.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu B, Lou X, Wu X, Ma L. Intra- and interscanner reliability and reproducibility of 3D whole-brain pseudo-continuous arterial spin-labeling MR perfusion at 3T. J Magn Reson Imaging 2014;39:402-409.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
